Legal Counsel at Bristol-Myers Squibb

Kariya-shi, Aichi, Japan

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Biotechnology, HealthcareIndustries

Requirements

Juris Doctor (JD) degree from an accredited law school
Active license to practice law in relevant jurisdiction(s)
Significant experience in corporate legal practice, preferably in pharmaceuticals, biotechnology, or life sciences
Strong knowledge of regulatory compliance, FDA regulations, intellectual property, contracts, and corporate governance
Excellent analytical, communication, and negotiation skills
Ability to handle confidential information with integrity
Willingness to comply with onsite protocol (site-essential or hybrid model requiring at least 50% onsite presence)
Full COVID-19 vaccination and up-to-date boosters strongly recommended

Responsibilities

Provide legal advice on corporate transactions, contracts, and commercial agreements
Ensure compliance with healthcare regulations, FDA requirements, and industry standards
Manage intellectual property matters, including patents, trademarks, and licensing
Support clinical trials, research collaborations, and global participation initiatives
Draft, review, and negotiate agreements with partners, vendors, and stakeholders
Mitigate legal risks in product development, manufacturing, and commercialization
Collaborate with cross-functional teams to promote innovation, accountability, and integrity
Represent the company in legal disputes, regulatory inquiries, and external meetings as needed

Skills

Legal Counsel

Corporate Law

Regulatory Compliance

Contract Negotiation

Risk Management

Pharmaceutical Law

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free